Skip to main content

PARADIGM CAPITAL MANAGEMENT INC/NY

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1037792 ALBANY, NY

Position in HALO

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$646,300
-$26,700 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

PARADIGM CAPITAL MANAGEMENT INC/NY holds $14,116,985 across 2 Biotechnology names. HALO ranks #2 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 HALO
Halozyme Therapeutics, Inc.
This page
10,000 $646,300

All Filings in HALO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $646,300 10,000
2025-12-31 $673,000 10,000
2025-09-30 $733,400 10,000
2025-06-30 $520,200 10,000
2025-03-31 $638,100 10,000
2024-12-31 $478,100 10,000
2024-09-30 $572,400 10,000
2024-06-30 $523,600 10,000
2024-03-31 $406,800 10,000
2023-12-31 $369,600 10,000
2023-09-30 $382,000 10,000
2023-06-30 $360,700 10,000
2023-03-31 $381,900 10,000
2022-12-31 $569,000 10,000
2022-09-30 $395,400 10,000
2022-06-30 $440,000 10,000
2022-03-31 $398,800 10,000
2021-12-31 $402,100 10,000
2021-09-30 $406,800 10,000
2021-06-30 $454,100 10,000
2021-03-31 $416,900 10,000
2020-12-31 $427,100 10,000
2020-09-30 $262,800 10,000
2020-06-30 $268,100 10,000
2020-03-31 $179,900 10,000